Cooley M&A

OCTOBER 29, 2020

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. Valuation Certainty.

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

How2Exit

APRIL 8, 2024

rn Episode Summary: rn In this episode of the How2Exit podcast, host Ronald Skelton welcomes Dominic Wells to discuss the landscape of business acquisitions, particularly in the context of a rapidly evolving market influenced by concerns around AI, economic stability, and business valuations. rn "There's a lot of attractive opportunities.

M&A 130

M&A Acquisitions Business Public Trading 130

The Deal

OCTOBER 17, 2023

Direct-to-consumer businesses, darlings of the investor community in 2021, saw their techlike valuations plummet. Public markets, however, have been tepid, with the much-awaited IPO of L Catterton Management Ltd. Public markets, however, have been tepid, with the much-awaited IPO of L Catterton Management Ltd.

M&A 64

M&A IPO Retail Medical 64

OfficeHours

OCTOBER 20, 2023

Furthermore, if the portfolio company’s revenue is not able to increase with or outpace the rate at which inflation is rising, its valuation will ultimately be impacted. High inflation might make IPOs more attractive as public markets can provide better protection against inflation whereas selling to strategic buyers or secondary buyers (i.e.

Investors 130

Investors Private Equity Equities Debt 130

Cooley M&A

MARCH 22, 2023

public company and a private target are being done on a simultaneous sign and close basis, with the issuance of common stock and non-voting preferred stock that does not require prior U.S. An IPO generally takes between four to six months, whereas a reverse merger can be completed in as little as three months.

Mergers 52

Mergers IT Mergers and Acquisitions IPO 52

Mergers and Inquisitions

SEPTEMBER 20, 2023

Technical Questions – You could get standard questions about accounting and valuation or VC-specific questions about cap tables, key metrics in your industry, or how to value startups. Q: Tell me about the current IPO, M&A, and VC funding markets. Q: Which current startup would you invest in?

Capital 59

Capital Valuation Investment Portfolio 59

Wall Street Mojo

JANUARY 17, 2024

read more like investors, shareholders Shareholders A shareholder is an individual or an institution that owns one or more shares of stock in a public or a private corporation and, therefore, are the legal owners of the company. In 2015, Box came up with its IPO. Before its IPO, Private Equity Investors financed Box Inc.

Accountant 98

Accountant Finance Finance Profitability 98

Software Equity Group

SEPTEMBER 17, 2024

Ownership Flexibility & Restrictions C Corps : C Corporations offer ownership flexibility, allowing unlimited shareholders and various classes of stock. citizens or residents, and allowing only one class of stock. The flexibility to have multiple stock classes is a major draw for institutional investors.

M&A 52

M&A Corporation Stock Investors 52

Peak Frameworks

SEPTEMBER 19, 2023

A shareholder is an individual or entity that owns shares or stock in a corporation. For example, in the 2012 Facebook IPO, common shareholders gained exposure to the tech giant's fortunes, while also securing a say in corporate matters. company to hit a $1 trillion valuation , it directly benefited shareholders.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Francine Way

JULY 8, 2017

PE funds typically have 4-to-7-years ownership windows for an investment and look for an exit at the end of that period through a sale or an IPO (initial public offering). Peaked market valuations: When market cycle peaks or an industry fully matures, it may be advantageous for shareholders to cash out.

M&A 130

M&A Acquisitions Sale Investment 130

InvestmentBank.com

JANUARY 14, 2021

Second, the IPO market, a key exit avenue for VC investments, proved increasingly strong and resilient throughout the year. These were just a few of many strong IPOs seen this year. As of December 23rd, 2020, US stock markets saw 477 IPOs, more than doubling the 233 IPOs from 2019, at least 120 of which were venture-backed [14] [11].

Capital 40

Capital IPO S&P Hospitality 40

Mergers and Inquisitions

MAY 24, 2023

They have their investment thesis and valuation, and the earnings announcement is the event that unlocks value… …but this is not what “event-driven” means in most cases. But even if the specific catalysts never materialize, the stock price might still increase by 20% or 30%. EBITDA multiple , matching its own.

Funds 64

Funds Investors Mergers and Acquisitions Mergers 64

Cooley M&A

JANUARY 23, 2024

Complex and novel transaction structures for the sector also were a prominent result of the market and regulatory environment, with reverse mergers remaining a fixture and stock-for-stock deals and take-private transactions led by private equity sponsors entering the scene. The results Add all those things together and what do we get?

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Mergers and Inquisitions

MARCH 13, 2024

This style is about purchasing minority stakes in cash-flow-negative-but-high-growth companies that want to scale and eventually go public or sell (think: Uber or Airbnb before their IPOs). Valuations are high, the returns depend on future growth, and deals are for primary capital , i.e., new cash the business needs.

Private Equity 105

Private Equity Equities Capital Portfolio 105

Cooley M&A

JANUARY 22, 2021

Despite dealmaking anxieties in the first half of the year, valuations remained strong, and discount opportunities were few and far between. Creative deal terms and financing arrangements were also attractive aspects of SPAC deals as compared to their IPO cousin. 2] Global deal value in the technology sector was up 47.3%

M&A 40

M&A IPO Mergers and Acquisitions Business 40

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. Let’s dig in. It’s a more challenging market environment right now than we’ve seen in many years,” said Charlie Kim , who co-chairs Cooley’s capital markets practice.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

FEBRUARY 7, 2023

Companies lacking cash turned to M&A to provide liquidity, while companies with cash on hand were able to capitalize on depressed valuations and undertake strategic transactions.

M&A 59

M&A Mergers and Acquisitions Mergers Finance 59

Cooley M&A

JANUARY 22, 2021

Even after Thermo Fisher raised its price to €43 per share, the tender offer failed and Qiagen’s stock has continued to trade above the offered price since the offer terminated in mid-August 2020. Earnouts continue to be popular methods for addressing valuation uncertainty, particularly in the life sciences space.

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

M&A Leadership Council

JUNE 12, 2023

Second, impact to deal valuation or terms. Concerning valuation or deal terms, the earlier you detect a breach or a strong possibility of a breach, the better so you can help corporate development decide how best to address the issues. MH: We often talk about due diligence findings in three successive phases.

IT 52

IT M&A Insurance Securities 52

M&A Leadership Council

SEPTEMBER 9, 2021

Second, impact to deal valuation or terms. Concerning valuation or deal terms, the earlier you detect a breach or a strong possibility of a breach, the better so you can help corporate development decide how best to address the issues. MH: We often talk about due diligence findings in three successive phases.

IT 52

IT M&A Insurance Securities 52

Cooley M&A

JANUARY 20, 2022

Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years. These players have looked further afield to add new capabilities and pipeline assets. DeSPAC transactions also hit an all? time highs in 2021.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

FEBRUARY 1, 2024

As a result, we saw an uptick in stock and earnout consideration , private company mergers of equals and carve out transactions throughout the year. 2] The moribund IPO market was a major contributor to this decline: There have been no sponsor-backed tech IPOs in the US since 2021.

M&A 59

M&A Mergers and Acquisitions Private Equity Equities 59

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

NOVEMBER 18, 2024

.* *FOCUS research I suspect we would have already seen several of these exits were it not for various factors including high valuation targets relative to market demand. Public Markets: It is possible that a few of the car wash platforms with strong growth and financial performance pursue an initial public offering (IPO).

Private Equity 52

Private Equity Equities IPO Valuation 52

Mergers and Inquisitions

NOVEMBER 20, 2024

Reference any deals you’ve worked on that required analysis of these points and talk about how they affected the valuation or client’s decisions (this is more grounded than just saying, “I like high-growth companies!”). Exits Up Slightly But Still Poor – M&A activity has ticked up modestly, but the IPO market is still mostly shut.

Private Equity 59

Private Equity Equities Capital Valuation 59

Mergers and Inquisitions

MARCH 5, 2025

Many biotech stocks are relatively uncorrelated with the broader market because they trade based on catalysts rather than GDP growth, inflation, interest rates, or consumer spending. Biotech stocks let hedge funds bet on very specific aspects of company performance. Its not just Will the drug succeed?

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64

Cooley M&A

JANUARY 22, 2025

This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market. Of course, the targets leverage in the M&A track of a dual-track process inherently increases when the IPO track is a viable strategy.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

Cooley M&A

FEBRUARY 3, 2025

The tech deal floodgates still havent opened, as persistent valuation mismatches, a still (mostly) closed tech IPO market, stiff competition and worldwide regulatory scrutiny continue to weigh on activity, particularly for VC-backed exits and mega deals. billion acquisition of Altair, IBMs pending $6.4 So is tech M&A back?

M&A 59

M&A Mergers and Acquisitions Private Equity Acquisitions 59